DRUG APPROVALS: APRIL 2011 

 

APRIL 6: HORIZANT (GABAPENTIN ENACARBIL)

TREATMENT- RESTLESS LEGS SYNDROME

 

APRIL 11: SYLATRON (PEGINTERFERON ALFA-2B)

TREATMENT- MALIGNANT MELANOMA

 

APRIL 23: DUEXIS (FAMOTIDINE & IBUPROFEN) TABLETS

TREATMENT- OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, NSAID-INDUCED ULCER PROPHYLAXIS

 

APRIL 28: ZYTIGA (ABIRATERONE) TABLETS

TREATMENT- PROSTATE CANCER